Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 86

1.

A general method to derive robust organ-specific gene expression-based differentiation indices: application to thyroid cancer diagnostic.

Tomás G, Tarabichi M, Gacquer D, Hébrant A, Dom G, Dumont JE, Keutgen X, Fahey TJ 3rd, Maenhaut C, Detours V.

Oncogene. 2012 Oct 11;31(41):4490-8. doi: 10.1038/onc.2011.626. Epub 2012 Jan 23.

PMID:
22266856
2.

Gene expression profiling of differentiated thyroid neoplasms: diagnostic and clinical implications.

Chevillard S, Ugolin N, Vielh P, Ory K, Levalois C, Elliott D, Clayman GL, El-Naggar AK.

Clin Cancer Res. 2004 Oct 1;10(19):6586-97.

3.

Gene expression in human thyrocytes and autonomous adenomas reveals suppression of negative feedbacks in tumorigenesis.

van Staveren WC, Solís DW, Delys L, Venet D, Cappello M, Andry G, Dumont JE, Libert F, Detours V, Maenhaut C.

Proc Natl Acad Sci U S A. 2006 Jan 10;103(2):413-8. Epub 2005 Dec 28.

4.

MicroRNA analysis as a potential diagnostic tool for papillary thyroid carcinoma.

Chen YT, Kitabayashi N, Zhou XK, Fahey TJ 3rd, Scognamiglio T.

Mod Pathol. 2008 Sep;21(9):1139-46. doi: 10.1038/modpathol.2008.105. Epub 2008 Jun 27.

6.

Differentiation of human follicular thyroid adenomas from carcinomas by gene expression profiling.

Zhao J, Leonard C, Gemsenjäger E, Heitz PU, Moch H, Odermatt B.

Oncol Rep. 2008 Feb;19(2):329-37.

PMID:
18202778
7.

Diagnostic and prognostic value of angiogenesis-modulating genes in malignant thyroid neoplasms.

Kebebew E, Peng M, Reiff E, Duh QY, Clark OH, McMillan A.

Surgery. 2005 Dec;138(6):1102-9; discussion 1109-10.

PMID:
16360397
8.

Immunohistochemical distinction of follicular thyroid adenomas and follicular carcinomas.

Bryson PC, Shores CG, Hart C, Thorne L, Patel MR, Richey L, Farag A, Zanation AM.

Arch Otolaryngol Head Neck Surg. 2008 Jun;134(6):581-6. doi: 10.1001/archotol.134.6.581.

PMID:
18559722
9.

Role of Ki-67 as a proliferative marker in lesions of thyroid.

Pujani M, Arora B, Pujani M, Singh SK, Tejwani N.

Indian J Cancer. 2010 Jul-Sep;47(3):304-7. doi: 10.4103/0019-509X.64727.

10.

Molecular profiling related to poor prognosis in thyroid carcinoma. Combining gene expression data and biological information.

Montero-Conde C, Martín-Campos JM, Lerma E, Gimenez G, Martínez-Guitarte JL, Combalía N, Montaner D, Matías-Guiu X, Dopazo J, de Leiva A, Robledo M, Mauricio D.

Oncogene. 2008 Mar 6;27(11):1554-61. Epub 2007 Sep 17.

PMID:
17873908
11.

Deregulation of microRNA expression in follicular-cell-derived human thyroid carcinomas.

Pallante P, Visone R, Croce CM, Fusco A.

Endocr Relat Cancer. 2010 Jan 29;17(1):F91-104. doi: 10.1677/ERC-09-0217. Print 2010 Mar. Review.

12.

Gene profiling identifies genes specific for well-differentiated epithelial thyroid tumors.

Puskas LG, Juhasz F, Zarva A, Hackler L Jr, Farid NR.

Cell Mol Biol (Noisy-le-grand). 2005 Sep 5;51(2):177-86.

PMID:
16171553
13.

Molecular markers for discrimination of benign and malignant follicular thyroid tumors.

Fryknäs M, Wickenberg-Bolin U, Göransson H, Gustafsson MG, Foukakis T, Lee JJ, Landegren U, Höög A, Larsson C, Grimelius L, Wallin G, Pettersson U, Isaksson A.

Tumour Biol. 2006;27(4):211-20. Epub 2006 May 2.

PMID:
16675914
14.

Micro-RNAs in thyroid neoplasms: molecular, diagnostic and therapeutic implications.

Menon MP, Khan A.

J Clin Pathol. 2009 Nov;62(11):978-85. doi: 10.1136/jcp.2008.063909. Epub 2009 Jul 21. Review.

PMID:
19625289
15.

Human thyroid tumor cell lines derived from different tumor types present a common dedifferentiated phenotype.

van Staveren WC, Solís DW, Delys L, Duprez L, Andry G, Franc B, Thomas G, Libert F, Dumont JE, Detours V, Maenhaut C.

Cancer Res. 2007 Sep 1;67(17):8113-20.

16.

MicroRNA expression profiling is a potential diagnostic tool for thyroid cancer.

Vriens MR, Weng J, Suh I, Huynh N, Guerrero MA, Shen WT, Duh QY, Clark OH, Kebebew E.

Cancer. 2012 Jul 1;118(13):3426-32. doi: 10.1002/cncr.26587. Epub 2011 Oct 17.

17.

[Flow cytometry of thyroid tumors. Study of fresh tissue in 50 patients].

Suissa J, Hoang C, Soubrane C, Chigot JP, Khayat D, Leenhardt L, Aurengo A, Turpin G, Le Charpentier Y.

Presse Med. 1994 Feb 5;23(4):159-63. French.

PMID:
8177857
18.

Patterns of expression of cell cycle/apoptosis genes along the spectrum of thyroid carcinoma progression.

Saltman B, Singh B, Hedvat CV, Wreesmann VB, Ghossein R.

Surgery. 2006 Dec;140(6):899-905; discussion 905-6.

PMID:
17188136
19.
20.

A molecular expression signature distinguishing follicular lesions in thyroid carcinoma using preamplification RT-PCR in archival samples.

Denning KM, Smyth PC, Cahill SF, Finn SP, Conlon E, Li J, Flavin RJ, Aherne ST, Guenther SM, Ferlinz A, O'Leary JJ, Sheils OM.

Mod Pathol. 2007 Oct;20(10):1095-102. Epub 2007 Jul 27.

Items per page

Supplemental Content

Write to the Help Desk